Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden

References

• Hammar M, Berg G, Fahraeus L, Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas 1984;6:345–50
   PubMed Web of Science ®Google Scholar
• McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–15
   PubMed Web of Science ®Google Scholar
• Avis NE, Ory M, Matthews KA, Schocken M, Bromberger J, Colvin A. Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women’s Health Across the Nation (SWAN). Med Care 2003;41:1262–76
   PubMed Web of Science ®Google Scholar
• Ledesert B, Ringa V, Breart G. Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas 1994;20:113–20
   PubMed Web of Science ®Google Scholar
• Shen W, Stearns V. Treatment strategies for hot flushes. Expert Opin Pharmacother 2009;10:1133–44
   PubMed Web of Science ®Google Scholar
• Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev2004(4):CD002978
   Google Scholar
• Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769–75
   PubMed Web of Science ®Google Scholar
• Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol 1988;128:606–14
   PubMed Web of Science ®Google Scholar
• Birkhauser M. Menopause in the aging society. In Takeshi A, Takumi Y, Seiichiro F, eds. The Menopause at the Millenium. New York: The Parthenon Publishing Group, 1999:101–7
   Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Herrington DM, Vittinghoff E, Lin F, et al. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). Circulation 2002;105:2962–7
   PubMed Web of Science ®Google Scholar
• Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
   PubMed Web of Science ®Google Scholar
• Phillips LS, Langer RD. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril 2005;83:558–66
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–77
   PubMed Web of Science ®Google Scholar
• Nedstrand E, Wijma K, Wyon Y, Hammar M. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study. Climacteric 2005;8:243–50
   PubMed Web of Science ®Google Scholar
• Cohen SM, Rousseau ME, Carey BL. Can acupuncture ease the symptoms of menopause?Holist Nurs Pract 2003;17: 295–9
   PubMedGoogle Scholar
• Nir Y, Huang MI, Schnyer R, Chen B, Manber R. Acupuncture for postmenopausal hot flushes. Maturitas 2007;56:383–95
   PubMed Web of Science ®Google Scholar
• Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 2009;25:166–74
   PubMed Web of Science ®Google Scholar
• Albertazzi P. Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric 2007;10(Suppl 2):115–20
   PubMed Web of Science ®Google Scholar
• Wyon Y, Wijma K, Nedstrand E, Hammar M. A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric 2004;7: 153–64
   PubMed Web of Science ®Google Scholar
• Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes?Acta Obstet Gynecol Scand 1990;69:409–12
   PubMed Web of Science ®Google Scholar
• Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998;29: 139–46
   PubMed Web of Science ®Google Scholar
• Daley A, Stokes-Lampard H, Macarthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev2011(5): CD006108
   Google Scholar
• Lindh-Astrand L, Brynhildsen J, Hoffmann M, Kjellgren KI, Hammar M. Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study. Menopause 2007;14:1039–46
   PubMed Web of Science ®Google Scholar
• Tao M, Teng Y, Shao H, Wu P, Mills EJ. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PLoS One 2011;6:e24661
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Safety 2007;16:726–35
   PubMed Web of Science ®Google Scholar
• Ronning M, Blix HS, Harbo BT, Strom H. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose – are drug utilisation data comparable?Eur J Clin Pharmacol 2000;56:723–7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Collaborating Centre for Drug Statistics Methodology 2013-10-03. Available from: http://www.whocc.no
   Google Scholar
• Spetz AC, Fredriksson MG, Hammar ML. Hot flushes in a male population aged 55, 65, and 75 years, living in the community of Linkoping, Sweden. Menopause 2003;10:81–7
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J. Changes in women’s attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 2005;52:11–17
   PubMed Web of Science ®Google Scholar
• Spetz AC, Palmefors L, Skobe RS, et al. Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population. Menopause 2007; 14:999–1005
   PubMed Web of Science ®Google Scholar
• Berg G, Gottwall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60–62 in Linkoping, Sweden, in 1986. Maturitas 1988;10:193–9
   PubMed Web of Science ®Google Scholar
• Lindgren R, Berg G, Hammar M, Zuccon E. Hormonal replacement therapy and sexuality in a population of Swedish postmenopausal women. Acta Obstet Gynecol Scand 1993;72: 292–7
   PubMed Web of Science ®Google Scholar
• Hammar M, Brynhildsen J, Dabrosin L, et al. Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 1996;25:193–9
   PubMed Web of Science ®Google Scholar
• Cardini F, Lesi G, Lombardo F, van der Sluijs C, Group MMSC. The use of Complementary and Alternative Medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health 2010;10:7
   PubMed Web of Science ®Google Scholar
• Nachtigall LE, Baber RJ, Barentsen R, et al. Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Canada 2006;28: 279–89
   PubMedGoogle Scholar
• EMEA Public Statement on Herbal Medicinal Products containing Cimifugae racemosae Rhizoma (Black cohosh, root) – Serious hepatic reactions [press release], 2006
   Google Scholar
• Naser B, Schnitker J, Minkin MJ, de Arriba SG, Nolte KU, Osmers R. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause 2011;18: 366–75
   PubMed Web of Science ®Google Scholar
• Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev 2013;12:CD001395
   Google Scholar
• Bedell S, Nachtigall M, Naftolin F. The pros and cons of plant estrogens for menopause. J Steroid Biochem Molec Biol 2014;139:225–36
   PubMed Web of Science ®Google Scholar
• Shams T, Setia MS, Hemmings R, McCusker J, Sewitch M, Ciampi A. Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis. Alt Ther Health Med 2010;16:36–44
   PubMed Web of Science ®Google Scholar
• Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012;9: CD007244
   PubMedGoogle Scholar
• Blumel JE, Chedraui P, Baron G, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18: 778–85
   PubMed Web of Science ®Google Scholar
• Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54–65. BJOG 2012;119:40–50
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10: 197–214
   PubMed Web of Science ®Google Scholar
• Cordina-Duverger E, Truong T, Anger A, et al. Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France. PLoS One 2013;8:e78016
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Greyber E, Ormiston TM, Salpeter EE. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004;19:791–804
   PubMed Web of Science ®Google Scholar
• Thurston RC, El Khoudary SR, Sutton-Tyrrell K, et al. Vasomotor symptoms and insulin resistance in the Study of Women’s Health Across the Nation. J Clin Endocrinol Metab 2012;97:3487–94
   PubMed Web of Science ®Google Scholar
• Sturdee DW, MacLennan AH. The pendulum swings back; estrogen is now beneficial if started at the right time. Climacteric 2006;9:73–4
   PubMed Web of Science ®Google Scholar
• Tolonen H, Helakorpi S, Talala K, Helasoja V, Martelin T, Prattala R. 25-year trends and socio-demographic differences in response rates: Finnish adult health behaviour survey. Eur J Epidemiol 2006;21:409–15
   PubMed Web of Science ®Google Scholar
• Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999–2010. Obstet Gynecol 2012;120:595–603
   PubMed Web of Science ®Google Scholar
• Ettinger B, Wang SM, Leslie RS, et al. Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause 2012;19:610–15
   PubMed Web of Science ®Google Scholar